Skip to main navigation Skip to search Skip to main content

Combined therapy of temozolomide and ZD6474 (vandetanib) effectively reduces glioblastoma tumor volume through anti-angiogenic and anti-proliferative mechanisms

  • Sungkyunkwan University
  • Chungbuk National University
  • Seoul National University

Research output: Contribution to journal › Article › peer-review

17   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Combined therapy of temozolomide and ZD6474 (vandetanib) effectively reduces glioblastoma tumor volume through anti-angiogenic and anti-proliferative mechanisms'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science